Trexquant Investment LP Lannett CO Inc Transaction History

Trexquant Investment LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$2.91 - $4.83 $92,380 - $153,333	-31,746 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$4.17 - $5.74 $132,380 - $182,222	31,746 New	31,746 $148,000
Q4 2019 Feb 12, 2020	SELL	$8.49 - $12.81 $269,048 - $405,948	-31,690 Closed	0 $0
Q3 2019 Nov 08, 2019	SELL	$5.58 - $14.47 $145,241 - $376,639	-26,029 Reduced 45.1%	31,690 $355,000
Q2 2019 Aug 09, 2019	BUY	$5.22 - $9.08 $301,293 - $524,088	57,719 New	57,719 $350,000
Q4 2018 Feb 13, 2019	SELL	$3.43 - $6.19 $406,626 - $733,824	-118,550 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$4.75 - $14.5 $446,908 - $1.36 Million	94,086 Added 384.59%	118,550 $563,000
Q2 2018 Aug 07, 2018	BUY	$13.3 - $17.45 $325,371 - $426,896	24,464 New	24,464 $333,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.